Bone density predictors in active lupus nephritis
Part of Bones, joints & muscles, Immune system & allergy, Kidney & urinary clinical trials.
This study looks at how lupus nephritis (kidney inflammation from lupus) affects bone mineral density (bone strength). It may help doctors understand who is at risk for weak bones and plan better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with lupus nephritis (kidney inflammation caused by lupus).
- You are not on dialysis for end-stage kidney disease.
- You do not have other autoimmune conditions like rheumatoid arthritis.
- You do not have hepatitis B or C, diabetes, or cancer.
- You have not taken vitamin D supplements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.
This study looks at two blood tests (albumin/globulin ratio and platelet/albumin ratio) to see if they can help understand lupus nephritis, a serious kidney problem caused by lupus. If you have lupus nephritis, your participation may help improve how doctors monitor and manage this condition.
This study looks at whether simple blood tests can help doctors better understand and track kidney problems that occur in people with lupus. The goal is to see if these markers can predict how the disease will progress, which could help guide treatment.
This study looks at whether a blood test for a specific antibody can help doctors understand how active lupus kidney disease is. It may help guide treatment decisions for people with lupus nephritis.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
Hear when a new Bone Mineral Density and Lupus Nephritis Activity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.